Volume dodolan perusahaan affimed.com (AFMD)
Demand for lymphoma treatment remains stable and independent of macroeconomic conditions, as confirmed by Affimed (AFMD) actual sales. The value of 0.00 determines the current status of the parameter. Revenue growth is driven by partner payments and the success of "engager" antibody tests. To strengthen its position, Affimed is reducing costs, focusing on NK cells and seeking new B2B alliances within the immuno-oncology sector.
Rincian metrik komprehensif lan analitis Affimed NV (AFMD)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang Agregat marang Ekuitas Affimed|AFMD - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang ekuitas Affimed Therapeutics|AFMD - Gunggung utang perusahaan|Utang-utang marang aset resik Affimed N.V.|AFMD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Affimed|Likuiditas darurat affimed.com
- data bathi bisnis lan rasio investasi:
AFMD - Bathi resik|Prakiraan bathi resik Affimed|AFMD - Pangali P/E|Pangali Forward P/E Affimed Therapeutics|AFMD - Pangali PEG|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Affimed N.V.|AFMD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Affimed|AFMD - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan affimed.com|AFMD - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Affimed
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:Affimed
For an investor in Affimed (AFMD), which develops innovative immunotherapy for oncology centers, this indicator serves as a tool to verify actual commercial demand for anti-tumor drugs. By analyzing the company's sales efficiency, we track daily cash inflows from clients, allowing us to distinguish fundamental revenue growth from speculative momentum and assess the sustainability of the business model within the targeted drug segment.
Analisis perusahaan pesaing
Pendapatan lan volume dodolan argenx BVBA|Pendapatan perusahaan BioNTech SE (BNTX)|Abivax SA - Volume dodolan perusahaan|Pendapatan lan volume dodolan ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Total pendapatan perusahaan|Immunovant Corp - Pendapatan lan volume dodolan|KNSA - Pendapatan lan volume dodolan|GRFS: Pendapatan lan volume dodolan|Pendapatan tahunan perusahaan ADPT (adaptivebiotech.com)|CLDX (Celldex Therapeutics, Inc.) - Pendapatan lan volume dodolan|Aurinia Pharmaceuticals Inc - Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan BCRX|Pendapatan reged perusahaan Vera Corp|Pendapatan perusahaan Dianthus Therapeutics DNTH|PHVS - Dodolan perusahaan|AbCellera - Pendapatan lan volume dodolan|Total pendapatan perusahaan Tourmaline Bio Inc|PGEN: Pendapatan lan volume dodolan|Volume dodolan perusahaan PHAR|NKTR (Nektar Therapeutics) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan upstreambio.com|Pendapatan lan volume dodolan ZBIO|IMNM: Pendapatan tahunan perusahaan|Pendapatan perusahaan Gossamer Corp GOSS|KALV - Dodolan perusahaan|Septerna Inc - Pendapatan lan volume dodolan|PVLA (pieris.com) - Volume dodolan perusahaan|Savara (SVRA) - Pendapatan perusahaan|Pendapatan tahunan perusahaan RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Pendapatan lan volume dodolan|ATXS: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ENGN|Pendapatan lan volume dodolan rapt.com (RAPT)|Pendapatan perusahaan Aerovate Therapeutics JBIO|Pendapatan dodolan perusahaan ACRS|KYTX - Pendapatan perusahaan|Tiziana Life Sciences, Ltd. (TLSA) - Dodolan perusahaan|CABA: Pendapatan lan volume dodolan|ventyxbio.com (VTYX) - Pendapatan lan volume dodolan|Dodolan perusahaan THTX|AVTX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ELDN|Pendapatan reged perusahaan Agenus, Inc|Pendapatan perusahaan Climb Bio Inc CLYM|ZURA - Dodolan perusahaan|ATYR - Pendapatan perusahaan|Adagene (ADAG) - Dodolan perusahaan|IMA (ikenaoncology.com) - Dodolan perusahaan|Shattuck Labs (STTK) - Pendapatan lan volume dodolan|Pendapatan perusahaan Equillium Inc|Volume dodolan perusahaan CNTB (Connect Pharma)|Pendapatan lan volume dodolan IMUX|ATRA - Total pendapatan perusahaan|Pendapatan lan volume dodolan IFRX (InflaRx)|Pendapatan lan volume dodolan X4 Pharmaceuticals, Inc XFOR|Adicet - Pendapatan lan volume dodolan|Pendapatan tahunan perusahaan CELU|INMB: Pendapatan lan volume dodolan|Pendapatan tahunan perusahaan BRNS (Barinthus Biotherapeutics PLC)|KZR (Kezar Life Sciences, Inc) - Pendapatan lan volume dodolan|SAB Biotherapeutics Inc (SABS) - Pendapatan reged perusahaan|Pendapatan perusahaan Akari Therapeutics (AKTX)|Dodolan perusahaan enlivex.com ENLV|Pendapatan lan volume dodolan QTTB (Q32 Bio)|GeoVax Labs (GOVX) - Total pendapatan perusahaan|Edesa - Pendapatan lan volume dodolan|IBIO (iBio Corporation) - Volume dodolan perusahaan|CARM: Pendapatan lan volume dodolan|xtlbio.com (XTLB) - Pendapatan lan volume dodolan|BOLT (Bolt Biotherapeutics Inc.) - Pendapatan lan volume dodolan|HCW Biologics Inc - Pendapatan tahunan perusahaan|Pendapatan perusahaan Aptevo Therapeutics (APVO)|Dodolan perusahaan aimimmuno.com AIM|Pendapatan lan volume dodolan ADTX (Aditxt, Inc.)|GRI: Volume dodolan perusahaan|XRTX - Pendapatan perusahaan|Pendapatan tahunan perusahaan HIND|REVB: Pendapatan lan volume dodolan|Indaptus Corp - Pendapatan dodolan perusahaan|SCNI (Scinai Immunotherapeutics) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan CalciMedica Corp|Pendapatan perusahaan Allakos Inc. (ALLK)|HOOK (hookipapharma.com) - Pendapatan dodolan perusahaan|Pendapatan perusahaan IGM Biosciences IGMS|ITOS - Dodolan perusahaan|Ocean Biomedical, Inc. - Pendapatan lan volume dodolan|TCBP - Pendapatan lan volume dodolan|THRD (Third Harmonic Bio, Inc.) - Dodolan perusahaan
